Exploring a Mitochondria Targeting, Dinuclear Cyclometalated Iridium (III) Complex for Image-Guided Photodynamic Therapy in Triple-Negative Breast Cancer Cells

被引:10
|
作者
Neelambaran, Nishna [1 ,2 ]
Shamjith, Shanmughan [1 ,2 ]
Murali, Vishnu Priya [1 ,2 ]
Maiti, Kaustabh Kumar [1 ,2 ]
Joseph, Joshy [1 ,2 ]
机构
[1] Natl Inst Interdisciplinary Sci & Technol CSIR NII, Chem Sci & Technol Div CSTD, Thiruvananthapuram 695019, Kerala, India
[2] Acad Sci & Innovat Res AcSIR, Ghaziabad 201002, India
关键词
dinuclear iridium complex; reactive oxygen species (ROS); photosensitizers (PSs); photodynamic therapy (PDT); targeted therapy; apoptosis; METAL-COMPLEXES; LIVE CELL; PHOTOSENSITIZERS; METASTASIS; LYSOSOME; PROBES; AGENTS; DYES;
D O I
10.1021/acsabm.3c00883
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Photodynamic therapy (PDT) has emerged as an efficient and noninvasive treatment approach utilizing laser-triggered photosensitizers for combating cancer. Within this rapidly advancing field, iridium-based photosensitizers with their dual functionality as both imaging probes and PDT agents exhibit a potential for precise and targeted therapeutic interventions. However, most reported classes of Ir(III)-based photosensitizers comprise mononuclear iridium(III), with very few examples of dinuclear systems. Exploring the full potential of iridium-based dinuclear systems for PDT applications remains a challenge. Herein, we report a dinuclear Ir(III) complex (IRDI) along with a structurally similar monomer complex (IRMO) having 2-(2,4-difluorophenyl)pyridine and 4 '-methyl-2,2 '-bipyridine ligands. The comparative investigation of the mononuclear and dinuclear Ir(III) complexes showed similar absorption profiles, but the dinuclear derivative IRDI exhibited a higher photoluminescence quantum yield (Phi(p)) of 0.70 compared to that of IRMO (Phi(p) = 0.47). Further, IRDI showed a higher singlet oxygen generation quantum yield (Phi(s)) of 0.49 compared to IRMO (Phi(s) = 0.28), signifying the enhanced potential of the dinuclear derivative for image-guided photodynamic therapy. In vitro assessments indicate that IRDI shows efficient cellular uptake and significant photocytotoxicity in the triple-negative breast cancer cell line MDA-MB-231. In addition, the presence of a dual positive charge on the dinuclear system facilitates the inherent mitochondria-targeting ability without the need for a specific targeting group. Subcellular singlet oxygen generation by IRDI was confirmed using Si-DMA, and light-activated cellular apoptosis via ROS-mediated PDT was verified through various live-dead assays performed in the presence and absence of the singlet oxygen scavenger NaN3. Further, the mechanism of cell death was elucidated by an annexin V-FITC/PI flow cytometric assay and by investigating the cytochrome c release from mitochondria using Western blot analysis. Thus, the dinuclear complex designed to enhance spin-orbit coupling with minimal excitonic coupling represents a promising strategy for efficient image-guided PDT using iridium complexes.
引用
收藏
页码:5776 / 5788
页数:13
相关论文
共 50 条
  • [31] Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer
    Lin, Chang-Ching
    Lo, Miao-Chia
    Moody, Rebecca
    Jiang, Hui
    Harouaka, Ramdane
    Stevers, Nicholas
    Tinsley, Samantha
    Gasparyan, Mari
    Wicha, Max
    Sun, Duxin
    CANCER LETTERS, 2018, 438 : 165 - 173
  • [32] Triple-negative breast cancer treatment in xenograft models by bifunctional nanoprobes combined to photodynamic therapy
    Jesus, Viviane Paula dos Santos
    Vieira, Paula Fonseca Antunes
    Cintra, Ricardo Cesar
    'Anna, Luciana Barros Sant
    Zezell, Denise Maria
    Castilho, Maiara Lima
    Raniero, Leandro
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2022, 38
  • [33] Photodynamic therapy as a strategic ally in radiotherapy for triple-negative breast cancer: the importance of treatment order
    Silva, Camila Ramos
    Vieira, Daniel Perez
    de Freitas, Anderson Zanardi
    Ribeiro, Martha Simoes
    BREAST CANCER RESEARCH AND TREATMENT, 2025, : 687 - 697
  • [34] Fluorescence image-guided photodynamic therapy of cancer cells using a scanning fiber endoscope
    Woldetensae, Mikias H.
    Kirshenbaum, Mark R.
    Kramer, Greg M.
    Zhang, Liang
    Seibel, Eric J.
    OPTICAL FIBERS AND SENSORS FOR MEDICAL DIAGNOSTICS AND TREATMENT APPLICATIONS XIII, 2013, 8576
  • [35] Targeting Notch signaling in cancer stem-like cells of triple-negative breast cancer
    Murphy, Adrienne M.
    Ucar, Ayse D.
    Miele, Lucio
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (01)
  • [36] Targeting PP2A inhibits the growth of triple-negative breast cancer cells
    Uddin, Mohammed Hafiz
    Pimentel, Julio M.
    Chatterjee, Madhumita
    Allen, Joshu E.
    Zhuang, Zhengping
    Wu, Gen Sheng
    CELL CYCLE, 2020, 19 (05) : 592 - 600
  • [37] Targeting triple-negative breast cancer cells with a 01-integrin binding aptamer
    Pleiko, Karlis
    Haugas, Maarja
    Parfejevs, Vadims
    Pantelejevs, Teodors
    Parisini, Emilio
    Teesalu, Tambet
    Riekstina, Una
    MOLECULAR THERAPY NUCLEIC ACIDS, 2023, 33 : 871 - 884
  • [38] Pyridinium Rotor Strategy toward a Robust Photothermal Agent for STING Activation and Multimodal Image-Guided Immunotherapy for Triple-Negative Breast Cancer
    Ning, Shipeng
    Shangguan, Ping
    Zhu, Xinyan
    Ou, Xinwen
    Wang, Kaiyuan
    Suo, Meng
    Shen, Hanchen
    Lu, Xiuxin
    Wei, Xianqing
    Zhang, Tianfu
    Chen, Xiaoyuan
    Tang, Ben Zhong
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2025, 147 (09) : 7433 - 7444
  • [39] Supramolecular magnetonanohybrids for multimodal targeted therapy of triple-negative breast cancer cells
    Mansur, Alexandra A. P.
    Mansur, Herman S.
    Leonel, Alice G.
    Carvalho, Isadora C.
    Lage, Manuela C. G.
    Carvalho, Sandhra M.
    Krambrock, Klaus
    Lobato, Zelia I. P.
    JOURNAL OF MATERIALS CHEMISTRY B, 2020, 8 (32) : 7166 - 7188
  • [40] Circulating Tumor Cells after Neoadjuvant Therapy in Stage I-III Triple-negative Breast Cancer
    Hall, C.
    Laubacher, B.
    Anderson, A.
    Karhade, M.
    Kuerer, H. M.
    DeSnyder, S.
    Lucci, A.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S17 - S17